Barricaid
Ryan Drant is the Founder and Managing Partner of Questa Capital, a healthcare-focused venture capital and growth equity investment firm. Ryan previously spent nineteen years at New Enterprise Associates (www.nea.com), where he served as a general partner, Head of Healthcare Investing and a member of the NEA Management Committee. Prior to NEA, he was in the corporate finance group at Alex. Brown & Sons and started his career at Arthur Andersen & Co.
Ryan is a four-time nominee to the Forbes Midas List of top venture capital investors. In addition to Intrinsic Therapeutics, he is currently a director of Bicycle Health, Calyxo, ControlRad, Cortica, Dispatch Health, Eko, Eximis, Medrio and Spine Wave. Ryan also serves on the board of the Medical Device Manufacturers Association and the National Venture Capital Association. He received a Bachelor of Arts degree in Political Science from Stanford University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Barricaid
1 followers
Adjacent to a lumbar discectomy, the Barricaid® device is designed to close large defects (>5mm) in the annulus, which often lead to disc reherniation and/or disc collapse. Barricaid is a permanent implant with two components - an occlusion component and an anchor.